BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14722707)

  • 21. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the disruptions of prepulse inhibition and habituation of startle induced by alpha-ethyltryptamine.
    Martinez DL; Geyer MA
    Neuropsychopharmacology; 1997 Mar; 16(3):246-55. PubMed ID: 9138441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
    Bauernfeind AL; Dietrich MS; Blackford JU; Charboneau EJ; Lillevig JG; Cannistraci CJ; Woodward ND; Cao A; Watkins T; Di Iorio CR; Cascio C; Salomon RM; Cowan RL
    Neuropsychopharmacology; 2011 May; 36(6):1127-41. PubMed ID: 21326196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA.
    Pettie M; Oakly A; Harper DN; Ellenbroek BA
    J Psychopharmacol; 2019 Mar; 33(3):355-363. PubMed ID: 30665313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of different doses of caffeine on habituation of the human acoustic startle reflex.
    Schicatano EJ; Blumenthal TD
    Pharmacol Biochem Behav; 1995 Sep; 52(1):231-6. PubMed ID: 7501671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive function in abstinent MDMA ('ecstasy') users.
    Zakzanis KK; Young DA
    Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.
    Gouzoulis-Mayfrank E; Heekeren K; Thelen B; Lindenblatt H; Kovar KA; Sass H; Geyer MA
    Behav Pharmacol; 1998 Nov; 9(7):561-6. PubMed ID: 9862081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    McCann UD; Edwards RR; Smith MT; Kelley K; Wilson M; Sgambati F; Ricaurte G
    Psychopharmacology (Berl); 2011 Oct; 217(4):475-84. PubMed ID: 21603895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
    Booij L; Soucy JP; Young SN; Regoli M; Gravel P; Diksic M; Leyton M; Pihl RO; Benkelfat C
    J Neurochem; 2014 Dec; 131(5):634-44. PubMed ID: 25041501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memory impairment in abstinent MDMA ("Ecstasy") users.
    Bolla KI; McCann UD; Ricaurte GA
    Neurology; 1998 Dec; 51(6):1532-7. PubMed ID: 9855498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does sensitization occur to prepulse inhibition of the startle reflex effects of repeated apomorphine treatments in rats?
    Martin-Iverson MT
    J Psychopharmacol; 1999; 13(3):261-73. PubMed ID: 10512082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic MDMA (ecstasy) use, cognition and mood.
    McCardle K; Luebbers S; Carter JD; Croft RJ; Stough C
    Psychopharmacology (Berl); 2004 May; 173(3-4):434-9. PubMed ID: 15088077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.